Website stats for Cosentyx - cosentyx.com
Do not use COSENTYX if you have had a severe allergic reaction to secukinumab or any of the other ingredients in COSENTYX. See the Medication Guide for a complete list of ingredients. COSENTYX is a medicine that affects your immune system. COSENTYX may increase your risk of having serious side effects such as: Infections COSENTYX may lower the ability of your immune system to fight infections and ...
cosentyx.com was registered 1 decade 2 years ago. It has a alexa rank of #648,810 in the world. It is a domain having .com extension. It is estimated worth of $ 1,920.00 and have a daily income of around $ 8.00. As no active threats were reported recently, cosentyx.com is SAFE to browse.
Traffic Report
| Daily Unique Visitors: | 1,351 |
| Daily Pageviews: | 2,702 |
Estimated Valuation
| Income Per Day: | $ 8.00 |
| Estimated Worth: | $ 1,920.00 |
Search Engine Indexes
| Google Indexed Pages: | Not Applicable |
| Yahoo Indexed Pages: | Not Applicable |
| Bing Indexed Pages: | 6 |
Search Engine Backlinks
| Google Backlinks: | Not Applicable |
| Bing Backlinks: | 4 |
| Alexa BackLinks: | Not Applicable |
Safety Information
| Google Safe Browsing: | No Risk Issues |
| Siteadvisor Rating: | Not Applicable |
| WOT Trustworthiness: |
 Very Poor
|
| WOT Privacy: |
Very Poor
|
| WOT Child Safety: |
Very Poor
|
Website Ranks & Scores
| Alexa Rank: | 648,810 |
| PageSpeed Score: | 89 ON 100 |
| Domain Authority: |
49 ON 100 
|
| Bounce Rate: | Not Applicable |
| Time On Site: | Not Applicable |
Web Server Information
Hosted IP Address:
104.18.11.143
Hosted Country:
US
Location Latitude:
37.7757Location Longitude:
-122.395Traffic Classification
| Total Traffic: | 181.54K |
| Direct Traffic: | 14.49% |
| Referral Traffic: | 4.66% |
| Search Traffic: | 68.11% |
| Social Traffic: | 1.02% |
| Mail Traffic: | 0% |
| Display Traffic: | 11.72% |
Search Engine Results For cosentyx.com
Psoriatic Arthritis Treatment | COSENTYX® (secukinumab)
Read about the MOA, dosing, and efficacy of COSENTYX, a biologic injection approved to treat psoriatic arthritis (PsA). See full Prescribing & Safety Info.
Cosentyx subcutaneous: Uses, Side Effects, Interactions ... - WebMD
This medication is used to treat plaque psoriasis and certain types of arthritis (such as arthritis of the spine, psoriatic arthritis, ...
Cosentyx 150 mg solution for injection in pre-filled syringe - eMC
Cosentyx is indicated for the treatment of moderate to severe plaque psoriasis in adults who are candidates for systemic therapy.
Secukinumab | Side-effects, uses, time to work - Versus Arthritis
Secukinumab (trade name Cosentyx) is a type of biological therapy which interferes with the function of IL-17A proteins. This action modifies the immune ...
office resources to help you get patients started on cosentyx
COSENTYX Moderate to Severe Plaque Psoriasis (PsO) + Psoriatic Arthritis (PsA) Indications ... COSENTYX Ankylosing Spondylitis (AS) Indication.
Access Resources | COSENTYX® (secukinumab)| HCP
Access info about COSENTYX® for PsO, PsA, AS and nr-axSpA. Find resources and forms for your practice and patients. See full prescribing and safety info.
Cosentyx: Cost, side effects, dosage, and more - Medical News Today
12 Aug 2019 ... Cosentyx (secukinumab) is a prescription drug used to treat plaque psoriasis, psoriatic arthritis, and ankylosing spondylitis.
Treating Psoriasis and Psoriatic Arthritis with Cosentyx
Cosentyx (also known by its generic name secukinumab) was approved by the FDA for the treatment of moderate-to-severe plaque psoriasis in adults in January ...
Novartis Cosentyx® receives FDA approval for new indication to ...
17 Jun 2020 ... “This approval brings a new therapeutic option to people living with non-radiographic axial spondyloarthritis.” The approval of Cosentyx for nr- ...
Cosentyx Prices, Coupons & Savings Tips - GoodRx
About Cosentyx. SECUKINUMAB is used to treat psoriasis. It is also used to treat psoriatic arthritis, ankylosing spondylitis, and active non-radiographic axial ...
COSENTYX® (secukinumab)
Learn more about COSENTYX (secukinumab), a prescription medication for treating moderate to severe plaque psoriasis, psoriatic arthritis, ...
NICE recommends Novartis' Cosentyx for children with severe ...
3 Sept 2021 ... Cosentyx is a monoclonal antibody designed to block IL-17A, a molecule which is involved in the psoriasis inflammatory response. According to ...
Video & Download - COSENTYX.ca
my tools and Resources. You will find useful information and guides about COSENTYX® treatment for psoriasis, an injection step card, a travel letter and a ...
Novartis Cosentyx receives FDA approval for treatment of children ...
1 Jun 2021 ... The safety profile of Cosentyx in pediatric patients with plaque psoriasis was demonstrated in two Phase III trials(1).
COSENTYX®secukinumab (@COSENTYXUSOnly) | Twitter
The latest Tweets from COSENTYX®secukinumab (@COSENTYXUSOnly). Let's move forward together, share ideas, and be inspired. Ask your questions by tweeting ...
Secukinumab - Wikipedia
Secukinumab, sold under the brand name Cosentyx, is a human IgG1κ monoclonal antibody that binds to the protein interleukin (IL)-17A, and is marketed by ...
NEW ZEALAND DATA SHEET - Medsafe
COSENTYX is indicated for the treatment of moderate to severe plaque psoriasis in adult patients who are candidates for systemic therapy or phototherapy.
Emerging Therapies - Cosentyx Launch Tracking Wave 1 (US)
Cosentyx's US label recommends use for the treatment of moderate to severe plaque psoriasis in adult patients who are candidates for systemic therapy or ...
COSENTYX® (secukinumab) - Deets Feedreader
10 Aug 2021 ... COSENTYX. Learn more about COSENTYX (secukinumab), a prescription medication for treating moderate to severe plaque psoriasis, psoriatic.
Cosentyx (Secukinumab): First IL-17A Antagonist Receives FDA ...
Cosentyx (Secukinumab): First IL-17A Antagonist Receives FDA Approval for Moderate-to-Severe Plaque Psoriasis · Cosentyx a New Treatment Option for Plaque ...
WATCH ME - HCP First by Novartis Pharmaceuticals Corporation
COSENTYX® (secukinumab) is a prescription medicine used to treat adults: • with moderate to severe plaque psoriasis that involves large areas or.
Cosentyx (secukinumab) - News, Articles etc. - European ...
Cosentyx (secukinumab) is manufactured by Novartis Pharma AG for the treatment of psoriasis, ankylosing spondylitis, and psoriatic arthritis.
Page Resources Breakdown
Homepage Links Analysis
Website Inpage Analysis
| H1 Headings: | 4 | H2 Headings: | 10 |
| H3 Headings: | 1 | H4 Headings: | Not Applicable |
| H5 Headings: | Not Applicable | H6 Headings: | Not Applicable |
| Total IFRAMEs: | 2 | Total Images: | 6 |
| Google Adsense: | Not Applicable | Google Analytics: | Not Applicable |
Two Phrase Analysis
| Words | Occurrences | Density | Possible Spam |
|---|---|---|---|
| your doctor | 12 | 0.808 % | No |
| if you | 9 | 0.606 % | No |
| you have | 9 | 0.606 % | No |
| for Use | 8 | 0.539 % | No |
| Instructions for | 8 | 0.539 % | No |
| with COSENTYX | 6 | 0.404 % | No |
| adults with | 6 | 0.404 % | No |
| treatment with | 6 | 0.404 % | No |
| with active | 6 | 0.404 % | No |
| Plaque Psoriasis | 5 | 0.337 % | No |
| Medication Guide | 5 | 0.337 % | No |
| of the | 5 | 0.337 % | No |
| side effects | 5 | 0.337 % | No |
| COSENTYX® Connect | 5 | 0.337 % | No |
| you get | 5 | 0.337 % | No |
| 150 mg | 4 | 0.269 % | No |
| starting COSENTYX | 4 | 0.269 % | No |
| of COSENTYX | 4 | 0.269 % | No |
| Prefilled Syringe | 4 | 0.269 % | No |
| Use Prefilled | 4 | 0.269 % | No |
Four Phrase Analysis
| Words | Occurrences | Density | Possible Spam |
|---|---|---|---|
| Real results Real relief | 4 | 0.269 % | No |
| people Real results Real | 4 | 0.269 % | No |
| Real people Real results | 4 | 0.269 % | No |
| mg Instructions for Use | 4 | 0.269 % | No |
| for Use Prefilled Syringe | 4 | 0.269 % | No |
| Instructions for Use Prefilled | 4 | 0.269 % | No |
| time Real people Real | 3 | 0.202 % | No |
| patient was compensated for | 3 | 0.202 % | No |
| COSENTYX if you have | 3 | 0.202 % | No |
| during treatment with COSENTYX | 3 | 0.202 % | No |
| tell your doctor if | 3 | 0.202 % | No |
| adult patient was compensated | 3 | 0.202 % | No |
| Actual adult patient was | 3 | 0.202 % | No |
| may vary Actual adult | 3 | 0.202 % | No |
| if you have any | 3 | 0.202 % | No |
| For adults with active | 3 | 0.202 % | No |
| results may vary Actual | 3 | 0.202 % | No |
| vary Actual adult patient | 3 | 0.202 % | No |
| your doctor if you | 3 | 0.202 % | No |
| Medication Guide Instructions for | 3 | 0.202 % | No |
Websites Hosted on Same IP (i.e. 104.18.11.143)
HTTP Header Analysis
Status-Code: 200
Status: 200 OK
Date: Tue, 28 Sep 2021 17:30:14 GMT
Content-Type: text/html; charset=UTF-8
Transfer-Encoding: chunked
Connection: keep-alive
Cache-Control: public, max-age=3600
X-Drupal-Dynamic-Cache: HIT
Link:
X-UA-Compatible: IE=edge
Content-language: en
X-Content-Type-Options: nosniff
X-Frame-Options: SAMEORIGIN
Expires: Tue, 28 Sep 2021 18:30:14 GMT
Last-Modified: Mon, 27 Sep 2021 08:03:56 GMT
Vary: Cookie,Accept-Encoding
X-Generator: Drupal 8 (https://www.drupal.org)
X-Drupal-Cache: MISS
X-Request-ID: v-76b66f10-1f69-11ec-bcb6-cffee394bc60
X-AH-Environment: prod
Age: 218
Via: varnish
X-Cache: HIT
X-Cache-Hits: 20
CF-Cache-Status: HIT
Expect-CT: max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
Strict-Transport-Security: max-age=31536000
Server: cloudflare
CF-RAY: 695eb2d36f195b98-FRA
Content-Encoding: gzip
Domain Information
| Domain Registrar: |
MarkMonitor Inc.
|
|---|---|
| Registration Date: | 2012-11-07 1 decade 2 years 2 weeks ago |
| Last Modified: | 2020-12-09 3 years 11 months 2 weeks ago |
Domain Nameserver Information
| Host | IP Address | Country | |
|---|---|---|---|
| a7-64.akam.net | |
23.61.199.64 | United States |
| a9-65.akam.net | |
184.85.248.65 | United States |
| dns1.novartis.com | |
160.62.4.7 |  Switzerland |
| dns2.novartis.com | |
160.62.7.59 | Switzerland |
| dns3.novartis.com | |
160.62.14.115 | Switzerland |
| dns4.novartis.com | |
160.62.14.116 | Switzerland |
DNS Record Analysis
| Host | Type | TTL | Extra |
|---|---|---|---|
| cosentyx.com | A | 86394 |
IP: 104.18.10.143 |
| cosentyx.com | A | 86394 |
IP: 104.18.11.143 |
| cosentyx.com | NS | 1800 |
Target: dns2.novartis.com |
| cosentyx.com | NS | 1800 |
Target: dns1.novartis.com |
| cosentyx.com | NS | 1800 |
Target: a7-64.akam.net |
| cosentyx.com | NS | 1800 |
Target: a1-254.akam.net |
| cosentyx.com | NS | 1800 |
Target: a24-65.akam.net |
| cosentyx.com | NS | 1800 |
Target: a9-65.akam.net |
| cosentyx.com | NS | 1800 |
Target: dns4.novartis.com |
| cosentyx.com | NS | 1800 |
Target: a28-67.akam.net |
| cosentyx.com | NS | 1800 |
Target: dns3.novartis.com |
| cosentyx.com | NS | 1800 |
Target: a2-66.akam.net |
| cosentyx.com | SOA | 86400 |
MNAME: dns1.novartis.com RNAME: hostmaster.novartis.com Serial: 2021072402 Refresh: 86400 Retry: 3600 Expire: 2592000 |
| cosentyx.com | TXT | 86400 |
TXT: a0610c6cf4954487bde785471afec090 |
| cosentyx.com | TXT | 86400 |
TXT: QuoVadis=6b904572-a84a-49ff-80a8-01f93c4 c72f8 |
| cosentyx.com | TXT | 86400 |
TXT: facebook-domain-verification=hzzz6qx4xh2 zds2xo4g3ap2wwgrfr0 |
| cosentyx.com | TXT | 86400 |
TXT: google-site-verification=7qw_pr0XHej6p1N KpPDbX2VXjnvOdVrBjjfAJQeGnqY |
| cosentyx.com | TXT | 86400 |
TXT: 0d0301ff99fa4fecb70b0bb110144d3a |
| cosentyx.com | TXT | 86400 |
TXT: _globalsign-domain-verification=7sds8V_y xJs85tGBzTrGJBW_-FnpvcQ_6INfh5MCna |
| cosentyx.com | TXT | 86400 |
TXT: f21836be17e04e31945d30b535906073 |
Top Organic Keyword
| 1. | cosentyx |
| 2. | ankylosing spondylitis |
| 3. | what are the early warning signs of psoriatic arthritis |
| 4. | consentix |
| 5. | can cosentyx cause weight gain |
Top Paid Keyword
| 1. | cosentyx |
| 2. | plaque psoriasis |
| 3. | ankylosing spondylitis |
| 4. | what is ankylosing spondylitis |
| 5. | psoriatic arthritis |
Top Referral Site
| 1. | topicsmedia.com |
| 2. | go.cnn.com |
| 3. | definition.org |
| 4. | fastquickanswer.com |
| 5. | needymeds.org |
Top Destination Site
| 1. | novartis.us |
| 2. | cosentyxhcp.com |
| 3. | novartisusa.secure.force.com |
Full WHOIS Lookup
Registry Domain ID:
1757476118_DOMAIN_COM-VRSN
Registrar WHOIS Server:
whois.markmonitor.com
Registrar URL:
http://www.markmonitor.com
Updated Date:
2020-12-08T22:09:39Z
Creation Date:
2012-11-06T17:07:11Z
Registry Expiry Date:
2022-11-06T17:07:11Z
Registrar: MarkMonitor Inc.
Registrar
IANA ID: 292
Registrar Abuse Contact Email:
[email protected]
Registrar Abuse Contact Phone:
+1.2083895740
Domain Status: clientDeleteProhibited
https://icann.org/epp#clientDeleteProhibited
Domain Status:
clientTransferProhibited
https://icann.org/epp#clientTransferProhibited
Domain Status:
clientUpdateProhibited
https://icann.org/epp#clientUpdateProhibited
Name Server:
A1-254.AKAM.NET
Name Server: A2-66.AKAM.NET
Name Server:
A24-65.AKAM.NET
Name Server: A28-67.AKAM.NET
Name Server:
A7-64.AKAM.NET
Name Server: A9-65.AKAM.NET
Name Server:
DNS1.NOVARTIS.COM
Name Server: DNS2.NOVARTIS.COM
Name Server:
DNS3.NOVARTIS.COM
Name Server: DNS4.NOVARTIS.COM
DNSSEC:
unsigned
URL of the ICANN Whois Inaccuracy Complaint Form:
https://www.icann.org/wicf/
>>> Last update of whois database:
2021-09-28T17:30:04Z
Similarly Ranked Websites
Weatherford Independent School District
Weatherford Independent School District is located 20 miles west of Fort Worth. Home of the Kangaroos!
648,811 
$ 1,920.00
Official Homepage | MINI Canada
Welcome to the official home of Canadian motoring. Discover the newest MINI models, latest special offers, and much more from the exciting world of MINI.
648,816 $ 1,920.00
Jävligt gott - en blogg om vegetarisk mat och vegetariska recept...
Vegetariska recept, restauranger och matlagningningstips. Allt med målet att sprida, laga och inspirera till jävligt god och helt vegetarisk mat som är enkel
648,833 $ 1,920.00
Interneta veikals | Baltic Data
Baltic Data ir 13 veikali, interneta veikals, vairumtirdzniecība, datoru serviss. Grāmatvedības un noliktavas programma Office Line, Baltic Data Algas.
648,836 $ 1,920.00